PLUS1
76.69
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -1.23 | -1.58% | 76.69 | 76.04 | 78.35 | 77.94 | 77.92 | 17:40:57 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 59,768 | 7,599,838 | $ 77.12 | $ 586,074,351 | 10,923,801 | 65.25 - 92.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:47:37 | 40 | $ 76.69 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 193.57B | 2.52B | 2.52B | $ 46.84B | $ 9.69B | 3.81 | 19.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 14.56M | $ 2.26 | 2.95% | - | - |
Merck News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/09/2020 | 17:40 | Dow Jones News | Merck Animal Health Gets FDA Approval of Bravecto Monthly.. |
| 7/09/2020 | 16:30 | Business Wire | Merck Animal Health Receives U.S. FDA Approval of BRAVECTO®.. |
| 7/09/2020 | 07:29 | Dow Jones News | Merck Gets FDA Priority Review of Keytruda in Classical.. |
| 7/09/2020 | 06:45 | Business Wire | FDA Grants Priority Review to Merck’s Supplemental Biologics.. |
| 7/08/2020 | 16:30 | Business Wire | Merck Announces Appointment of Organon & Co. General Counsel |
| 7/08/2020 | 07:59 | Dow Jones News | AstraZeneca, Merck Get Europe OK for Lynparza in Pancreatic.. |
| 7/08/2020 | 06:55 | Business Wire | LYNPARZA® (olaparib) Approved in the EU for Germline.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 78.61 | 80.022 | 75.5392 | 78.64 | 7,108,751 | -1.92 | -2.44% |
| 1 Month | 80.97 | 81.66 | 73.572 | 76.78 | 10,716,929 | -4.28 | -5.29% |
| 3 Months | 82.96 | 84.75 | 73.572 | 78.73 | 10,707,387 | -6.27 | -7.56% |
| 6 Months | 89.07 | 92.0554 | 65.25 | 79.33 | 12,260,446 | -12.38 | -13.9% |
| 1 Year | 84.24 | 92.64 | 65.25 | 81.64 | 10,304,932 | -7.55 | -8.96% |
| 3 Years | 63.39 | 92.64 | 52.83 | 72.18 | 10,208,708 | 13.30 | 20.98% |
| 5 Years | 58.00 | 92.64 | 45.69 | 66.82 | 9,803,238 | 18.69 | 32.22% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
